Breakthrough trial aims to prevent lung damage in tiniest newborns
Prevention
Ongoing
This study tests an investigational drug called OHB-607 to see if it can prevent bronchopulmonary dysplasia (BPD), a serious chronic lung disease, in extremely premature infants. About 338 babies will be randomly assigned to receive either the drug or standard care. The goal is t…
Phase: PHASE2 • Sponsor: OHB Neonatology Ltd. • Aim: Prevention
Last updated Aug 05, 2026 00:00 UTC